Ion Exchange India Ltd (IONEXCHANG) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company's consolidated operations normalized during the quarter following the completion of its SAP environment migration, leading to improved execution.
- Overall operating income increased by 14% year-on-year, reflecting a recovery in business activity.
- The engineering division experienced a 16% year-on-year revenue increase, driven by sequential growth in order flow, particularly from medium-sized opportunities and projects in the solar and pharmaceutical segments.
- The chemical segment demonstrated strong performance with an 11% year-on-year revenue increase and a 13% year-on-year EBITDA increase, maintaining its margin profile due to consistent operational performance.
- The consumer product division recorded healthy volume growth, with revenue increasing by 24% year-on-year, driven by focused marketing strategies and market share expansion.
- The company commenced the stage-wise commissioning and commercialization of its Greenfield manufacturing plant at Roha, Maharashtra, strengthening manufacturing capabilities for ion exchange resins.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.